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Abstract 
Pregnancy is a physiologically immunocompromised state, during which alterations in T-lymphocyte subsets may occur. 
Reference values for CD4 counts in pregnancy have not been established particularly in sub-Saharan populations. This 
study aimed at describing expected (‘normal’) values of CD4 counts in healthy HIV-negative pregnant women so these 
could serve as reference for assessing the progress of HIV disease in HIV-infected pregnant women.  
The study was conducted in antenatal clinics in the Buea Health District, Cameroon. All eligible women were interviewed 
using a standardized questionnaire. Whole blood samples collected were tested for HIV using Determine 1/2 and SD 
Bioline HIV-1/2 3.0 rapid tests. The CD4+ absolute counts were assessed using the Partec Cyflow Counter and the CD4 easy 
count kit. A total of 279 women were analysed. Their ages ranged from 15 to 47 years. A vast majority (95%) of participants 
were in the second or third trimester of gestation. Slightly less than half (43%) were primiparous. The CD4 cell count ranged 
from 321 to 1808 cells/µl . This distribution was approximately normal with a mean of 851cells/µl, a median of 831cells/µl , 
and a standard deviation of 254cells/µl . The expected (‘normal’) range, covering 95% of the sample was 438-1532 cells/µl. 
Participants with malaria parasitaemia tended to have a lower CD4 count (lower on average by 115 cells/µl, P<0.001). CD4 
cell counts in HIV-negative pregnant women appear similar to those of the general population of HIV-negatives. These 
values can thus be used as references when assessing HIV-seropositive pregnant women.  
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Introduction 
CD4 counts are widely used as prognostic markers 
to assess the degree of immune impairment in HIV 
seropositive individuals and treatment decisions are 
based on this. They are also used to monitor 
antiretroviral therapy (ART)[1,2,3,4,5]. Indeed the 
most recent WHO guidelines on HIV treatment 
recommend the use of CD4 counts to determine the 
need for combination antiretroviral therapy in HIV-
positive patients, including pregnant women.  In 
2005, a predictive values of CD4+ lymphocyte count 
in adult populations in Nigeria published [6]. Before 
then, reference values of CD4+-cells were not 
available from West African populations. Rather, 
values from publications based on studies in 
Western countries were largely employed for 
clinical decision making [6].  Evidence in literature 
suggest  significant geographical and racial 
differences in these parameters; for example, lower 
CD4+-cell counts have been recorded for Asians 
compared to Caucasians [7] and studies in African 
populations have shown mean CD4+cell counts in 
healthy Ethiopians that are markedly lower than 
those in Ugandans and Tanzanians [6].  
Reference values for CD4 counts in pregnancy are 
even less known particularly in sub-Saharan 
populations. Pregnancy is a physiologically 
immunocompromised state, during which 
alterations in T-lymphocyte subsets may occur [8,9]. 
Normal pregnancy has been described as an 
immune–suppressed state that is induced so that the 
foetus would not be rejected by the mother’s 
immune system. However, more recent evidence 
indicates that the immunology of both pregnancy 
and the sex steroid hormones is exceedingly 
complex and not fully understood [9]. The foetus is 
likely protected not by immune suppression in the 
mother but by changes in Human Leukocyte 
Antigen (HLA) expression in the trophoblast.  
Despite uncertainties on the variation of CD4 counts 
during pregnancy, CD4 counts are being used to 
assess the need for treatment in pregnant HIV-
positive women in Cameroon and most other 
resource limited settings. In practice, the CD4 
threshold for starting ART in pregnant women is 
the same as in non-pregnant populations. We 
hypothesized that this practice may be erroneous if 
it were confirmed that lower CD4 counts were to be 
expected in HIV-negative pregnant women. If the 
latter were true then the CD4 count threshold for 
initiating antiretroviral therapy in pregnancy may 
need to be lower than that in non-pregnant 
populations. There is therefore a need to establish 
expected (‘normal’) values of CD4 counts in healthy 
HIV-negative pregnant women so these could serve 
as reference for assessing the degree of progress in 
HIV disease in HIV-infected pregnant women. 
 
Materials and Methods  
This study was conducted in antenatal clinics 
(ANCs) in the Buea Health District of Cameroon. 
Two clinics, the Buea Road Health Centre (BRHC) 
and the Provincial Hospital Annex Buea (PHAB) 
were used. A previous survey of the ANCs in the 
29 
 
health district showed that these two ANCs had the 
highest number of pregnant women for prenatal 
care. Pregnant women attending these two ANCs 
were eligible and those who consented were 
included in the study.  All eligible and consenting 
women were interviewed using a standardized 
questionnaire. After which about 5ml of venous 
blood was collected by venipuncture from each 
participant into EDTA tubes. These samples were 
transported from collection sites to the Faculty of 
Health Science Laboratory, University of Buea, in a 
cooler containing ice. 
 
Once in the laboratory, the samples were tested 
immediately for HIV using Determine HIV1/2 
(Abbott Co. Ltd. , Japan) and  SD Bioline HIV-1/2 
3.0 rapid tests (Standard Diagnostics, INC., USA) 
This was done in conformity with the WHO 
recommendation Strategy 2 ; which states that HIV 
can be diagnosed using two rapid tests [10] and this 
is the diagnostic strategy used in HIV Treatment 
Centers in Cameroon. The CD4+ absolute counts 
were done using the Partec Cyflow Counter and the 
CD4 easy count kit (Partec GmbH, Germany).  
The samples were also tested for malaria using a 
fluorescent microscope  (Partec GmbH, Germany). 
10ul of whole blood from the EDTA tubes was 
placed onto the dried-in reagent spot on the test 
slides. The slides were tilted in all directions in 
order to distribute the drop of blood. Slides were 
covered with a cover slip and incubated for 5 
minutes. The slides were then placed under the 
Cyscope. The UV light was switched on and the 
prescence or not of parasites observed. 
Data Analysis 
Data collected were entered into an MS Access 
interface on Epi-info. Statistical analysis was 
conducted using STATA version 9 (STATA Corp., 
College Station, Texas, USA). Participants’ 
demographic characteristics and the variations in 
the CD4 cell counts in the whole sample were 
analysed. Variations in mean CD4 cell count (and its 
variance) by participant characteristics were then 
compared using Student’s t-tests (for characteristics 
with two categories) and ANOVA tests (for 
characteristics with more than 2 categories). A 
priori, the statistical significance level was set at 0.05 
while any difference in CD4 count of 100 or more 
was to be considered meaningful. 
 
Ethical considerations 
Ethical clearance for this study was obtained from 
the Regional Delegation of Public Health, Buea, 
Cameroon. Participation in this study was 
voluntary. A signed consent form was sought from 
all participants. All procedures were standard and 
only involved minimal risk to the participants. 
Study results were returned to patients and 




A total of 307 women were approached. Of these, 
12(3.9%) participants did not consent to HIV testing. 
Sixteen (5.2%) of the remaining 295 women tested 
positive for HIV.  All HIV-positive cases were 
excluded from this analysis. The age of participants 
ranged from 15 to 47 years with a mean (+/- 
standard deviation) of 26 years (+/- 5.56). Table 1 
summarises the participants’ characteristics. A vast 
majority (95%) of participants were either in the 
second or third trimester of gestation. Slightly less 
than half (43%) were primiparous. Questions on the 
means of accommodation (used as indicators of 
socio-economic status) revealed that 15% were 
living with relatives. 
The CD4 cell counts ranged from 321 to 1808 
cells/µl  of blood. The distribution of CD4 counts is 
shown in Figure 1. This distribution was 
approximately normal with a mean of 851cells/µl , a 
median of 831cells/µl , and a standard deviation of 
254cells/µl . The 2.5th percentile and 97.5th 
percentiles were estimated to be 438cells/µl  and 
1532cells/µl  respectively, suggesting an expected 
(‘normal’) range, covering 95% of the sample, of 438 
to1532 cells/µl . 
 
Table 2 shows the variations in the mean CD4 cell 
counts by participants’ characteristics. Overall, there 
was no substantial (nor statistically significant) 
variation in CD4 count with characteristics other 
than malaria. The mean CD4 cell count (SD) in 
malaria negative pregnant women was 927(275) 
cells/µl as compared to 818(236) cells/µl in malaria 
positive women.  
 
Figure 2 depicts the CD4 count distribution by 
malaria status. Malaria positive women still had a 
significantly lower CD4 cell count than malaria 
negative women: an average difference of 115 














TABLE 1: SUMMARY OF PARTICIPANTS’ CHARACTERISTICS 
 
Characteristics Number (%)* 
Period of gestation  
1st Trimester 15 (5.38) 
2nd Trimester 149 (53.41) 
3rd  Trimester 115 (41.22) 
Gravidity  
1 119 (42.65) 
2 52 (18.64) 
3 46 (16.49) 
4 34 (12.19) 
≥5 28 (10.05) 
Marital Status  
Single 61 (22.18) 
Married 184 (66.91) 
Divorced 9 (3.27) 
Widow 21 (7.64) 
Education  
No Education 9 (3.23) 
Primary 86 (30.82) 
Secondary 123 (44.09) 
Tertiary 61 (21.86) 
Means of accommodations  
Living with relative 42 (15.11) 
Renting 187 (67.27) 
Living in your own house 49 (17.63) 
 
*percentage based on number of respondents  
 
 





This study aimed at describing reference values of 
CD4 counts in HIV-negative pregnant women in 
Buea, South West Region of Cameroon, these CD4 
values were found to be normally distributed and 
similar to values described for non-pregnant HIV 
negative women in the literature. The study also 
established that demographic and socio-economic 





The mean CD4 values found in this population were 
within the range of values reported in other HIV-
negative populations. The mean CD4 count was 
higher, by 80 cells/µl, than the 771 (250) cells/µl , 
reported by Aina et al in 2005 in a population of 
HIV-negative adults in neighbouring Jos, Nigeria 
[6]. In the Central African Republic, the mean CD4 
value in non-pregnant females was 940cells/µl [3] a 
value which was higher, by 89 cells/µl, than that 
observed in our study of pregnant women. In 
Botswana mean CD4 T-lymphocyte counts (+/- SD) 



















827(+/- 245), [Bussmann et al, 2004]. Normal values 
for CD4 and CD8 T lymphocyte subsets in Shanghai 
was 727/540 cells / ul Jiang et al, 2004. In another 
study, mean CD4 T cell values (+/- standard 
deviation) for adult populations in other non-
African population were; Chinese 812(+/- 255), 
Malaysian 856 (+/- 308), Indian 958(+/-296) and 
Hong Kong 812(+/-256) [5].  
Similar to our findings, other studies have found 
little or no relationships between socio-demograhic 
characteristics and CD4 count levels. A study [6] 
found no association between gestational ages with 
CD4 counts. In another investigation carried out on 
peripheral blood lymphocyte subsets in adolescents, 
age had no effect on the CD4 + cell counts in the 
female participants and was found to have no 
correlation with CD4 lymphocyte count [12].  
In this study malaria positive pregnant women 
tended to have significantly lower CD4 counts. This 
has also been reported in non-pregnant adult 
populations [13], and in HIV and malaria positive 
adults[Chalwe et al, 2009]. In these studies the CD4 
count in malaria positive participants was lower by 
about 300cells/µl  and more than 400cells/µl  
respectively. These lower CD4 counts in malaria 
could be a result of malaria infection impairing the 
normal functioning of the immune system [10,15]. 
Pregnant women are susceptible to malaria during 
pregnancy. Plasmodium falciparum sequesters in the 
placenta. Parasitized cells in the placenta express 
unique variant surface antigens (VSA) and lack of 
immunity to these pregnancy-specific variant 
surface antigens explains some of the pregnancy-
associated malaria susceptibility. Peripheral blood 
T-cell responses may be decreased in malaria and 
this may be due to trafficking of memory T-cells out 
of the circulation [16]. 
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*adjusted for all listed characteristics, obtained using linear regression. Ref=reference level in the comparison of means            
 
If confirmed that pregnant malaria positive women 
tended to have a lower CD4 count, the malaria 
status would need to also be taken into account 
when assessing the need for antiretroviral therapy 
in an HIV-positive woman. Given the cross-
sectional nature of the study, we could not establish 
the long-term evolution of CD4 counts in these 
malaria positive women. It will be interesting to 
know whether the low-CD4 counts are only 
transient and increase after malaria treatment. In 
which case, in assessing HIV-positive women, a 
repeat CD4 assay may be needed in the pregnant 
women who are also malaria positive, before 
deciding if they need to be placed on antiretroviral 
therapy. 
This study’s findings may however be hampered by 
some limitations. First, the study was conducted in 
only one health district and may thus not be 
representative of the whole country. Secondly, HIV 
serostatus was determined using rapid tests only – 
some cases of acute HIV may have been 
misdiagnosed as being HIV-negative. We suspect 
that this would have resulted only in a slight 
underestimation of the mean CD4 counts as the 
cases of acute HIV would not yet have started 




Most studies have reported mean CD4 values of 
normal adult populations and non pregnant 
females. Reference values for HIV-negative 
pregnant women are rare in the literature. In this 
study we report reference values of mean CD4 T-
cell counts of pregnant women in Buea, Cameroon. 
These values were similar to those of the general 
population of non-pregnant HIV-negative women.  
Knowledge of these values will be clinically useful 
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